CFD merupakan instrumen yang rumit dan memiliki risiko tinggi kehilangan uang secara cepat karena adanya pengaruh leverage. 84% akun investor ritel mengalami kerugian saat melakukan kegiatan perdagangan CFD dengan penyedia ini. Anda harus mempertimbangkan apakah Anda memahami cara kerja CFD dan apakah Anda mampu menerima risiko tinggi kehilangan uang.

Scan to Download iOS&Android APP

Perdagangan Biodesix, Inc. - BDSX CFD

1.7472
1.16%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.0356
Biaya inap posisi Long

Long position overnight fee


Margin. Your investment $1,000.00
Biaya Overnight -0.024068 %
Charges from borrowed part ($-0.96)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Kunjungi platform
-0.024068%
Biaya inap posisi short

Short position overnight fee


Margin. Your investment $1,000.00
Biaya Overnight 0.001846 %
Charges from borrowed part ($0.07)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Kunjungi platform
0.001846%
Waktu biaya inap 21:00 (UTC)
Kuantitas min. yang diperdagangkan 1
Mata uang USD
Margin 20%
Bursa efek United States of America
Komisi perdagangan 0%

*Information provided by Capital.com

Key Stats
Prev. Close* 1.7172
Open* 1.6972
1-Year Change* -1.33%
Day's Range* 1.6972 - 1.7571
52 wk Range 0.96-3.00
Average Volume (10 days) 142.92K
Average Volume (3 months) 2.52M
Market Cap 134.90M
P/E Ratio -100.00K
Shares Outstanding 77.97M
Revenue 38.21M
EPS -1.60
Dividend (Yield %) N/A
Beta -100.00K
Next Earnings Date May 9, 2023

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Mar 28, 2023 1.7172 0.0100 0.59% 1.7072 1.7372 1.6473
Mar 27, 2023 1.7072 -0.0200 -1.16% 1.7272 1.7272 1.6773
Mar 24, 2023 1.7073 0.0800 4.92% 1.6273 1.7073 1.6273
Mar 23, 2023 1.6174 -0.2596 -13.83% 1.8770 1.8770 1.6074
Mar 22, 2023 1.8570 0.0799 4.50% 1.7771 1.8969 1.7472
Mar 21, 2023 1.7771 0.0300 1.72% 1.7471 1.7871 1.7372
Mar 20, 2023 1.7172 -0.0399 -2.27% 1.7571 1.7771 1.6173
Mar 17, 2023 1.7571 -0.0300 -1.68% 1.7871 1.8670 1.7472
Mar 16, 2023 1.7871 -0.0799 -4.28% 1.8670 1.9070 1.7172
Mar 15, 2023 1.8770 0.2896 18.24% 1.5874 1.8870 1.5874
Mar 14, 2023 1.6373 -0.0100 -0.61% 1.6473 1.6973 1.6274
Mar 13, 2023 1.6473 0.1498 10.00% 1.4975 1.7172 1.4975
Mar 10, 2023 1.5675 0.1398 9.79% 1.4277 1.6573 1.3877
Mar 9, 2023 1.4776 -0.2096 -12.42% 1.6872 1.6873 1.4676
Mar 8, 2023 1.6673 -0.0898 -5.11% 1.7571 1.7971 1.6673
Mar 7, 2023 1.7771 0.0599 3.49% 1.7172 1.7971 1.7172
Mar 6, 2023 1.7572 -0.3194 -15.38% 2.0766 2.1366 1.7172
Mar 3, 2023 1.9668 0.0000 0.00% 1.9668 2.0467 1.9668
Mar 2, 2023 1.9668 -0.0300 -1.50% 1.9968 2.0368 1.9569
Mar 1, 2023 1.9868 -0.0399 -1.97% 2.0267 2.0467 1.9369

Biodesix, Inc. Events

Time (UTC) Country Event
No events scheduled
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 38.212 54.506 45.557 24.552 20.432
Revenue 38.212 54.506 45.557 24.552 20.432
Cost of Revenue, Total 14.154 30.518 21.998 6.074 4.406
Gross Profit 24.058 23.988 23.559 18.478 16.026
Total Operating Expense 95.78 93.148 68.491 51.293 44.095
Selling/General/Admin. Expenses, Total 58.458 47.958 32.328 30.637 25.899
Research & Development 13.102 12.789 10.818 10.468 8.188
Unusual Expense (Income) 7.062 -2.298 3.451 1.739
Other Operating Expenses, Total 0 1.622 0.818 0.663 3.863
Operating Income -57.568 -38.642 -22.934 -26.741 -23.663
Interest Income (Expense), Net Non-Operating -8.072 -4.508 -7.586 -2.953 -2.892
Other, Net 0.193 -0.009 -0.83 -1.032 0.389
Net Income Before Taxes -65.447 -43.159 -31.35 -30.726 -26.166
Net Income After Taxes -65.447 -43.159 -31.35 -30.726 -26.166
Net Income Before Extra. Items -65.447 -43.159 -31.35 -30.726 -26.166
Net Income -65.447 -43.159 -31.35 -30.726 -26.166
Income Available to Common Excl. Extra. Items -65.447 -43.159 -31.35 -30.726 -26.166
Income Available to Common Incl. Extra. Items -65.447 -43.159 -31.35 -30.726 -26.166
Diluted Net Income -65.447 -43.159 -31.35 -30.726 -26.166
Diluted Weighted Average Shares 42.103 27.365 26.5615 26.2541 26.2541
Diluted EPS Excluding Extraordinary Items -1.55445 -1.57716 -1.18028 -1.17033 -0.99665
Dividends per Share - Common Stock Primary Issue 0 0
Diluted Normalized EPS -1.38672 -1.66114 -1.14948 -1.03889 -0.93041
Depreciation / Amortization 3.004 2.559 2.529
Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021
Total revenue 9.607 11.107 10.95 6.548 7.224
Revenue 9.607 11.107 10.95 6.548 7.224
Cost of Revenue, Total 3.306 3.633 3.98 3.235 2.493
Gross Profit 6.301 7.474 6.97 3.313 4.731
Total Operating Expense 27.474 21.769 25.528 21.009 19
Selling/General/Admin. Expenses, Total 16.626 15.114 15.235 14.487 13.558
Research & Development 3.565 2.97 3.361 3.206 2.852
Unusual Expense (Income) 3.977 0.052 2.952 0.081 0.097
Operating Income -17.867 -10.662 -14.578 -14.461 -11.776
Interest Income (Expense), Net Non-Operating -2.55 -3.039 -1.346 -1.137 -1.496
Other, Net 0.079 0.002 0.1 0.012 -0.01
Net Income Before Taxes -20.338 -13.699 -15.824 -15.586 -13.282
Net Income After Taxes -20.338 -13.699 -15.824 -15.586 -13.282
Net Income Before Extra. Items -20.338 -13.699 -15.824 -15.586 -13.282
Net Income -20.338 -13.699 -15.824 -15.586 -13.282
Income Available to Common Excl. Extra. Items -20.338 -13.699 -15.824 -15.586 -13.282
Income Available to Common Incl. Extra. Items -20.338 -13.699 -15.824 -15.586 -13.282
Diluted Net Income -20.338 -13.699 -15.824 -15.586 -13.282
Diluted Weighted Average Shares 57.553 40.448 39.239 31.07 27.059
Diluted EPS Excluding Extraordinary Items -0.35338 -0.33868 -0.40327 -0.50164 -0.49085
Dividends per Share - Common Stock Primary Issue 0 0 0
Diluted Normalized EPS -0.28428 -0.3374 -0.32804 -0.49903 -0.48727
Other Operating Expenses, Total 0 0 0 0 0
  • Annual
  • Quarterly
2021 2020 2019 2018
Total Current Assets 43.613 86.14 12.7 9.913
Cash and Short Term Investments 32.712 62.126 5.286 5.914
Cash & Equivalents 32.712 62.126 5.286 5.914
Total Receivables, Net 3.656 15.304 5.292 1.892
Accounts Receivable - Trade, Net 3.656 15.304 5.292 1.892
Other Current Assets, Total 7.245 8.71 2.122 2.107
Total Assets 76.097 121.07 41.633 39.057
Property/Plant/Equipment, Total - Net 4.179 3.178 2.12 1.388
Property/Plant/Equipment, Total - Gross 10.928 9.902 8.506 6.956
Accumulated Depreciation, Total -6.749 -6.724 -6.386 -5.568
Goodwill, Net 15.031 15.031 11.631 10.804
Intangibles, Net 11.617 13.26 15.092 16.852
Other Long Term Assets, Total 1.657 3.461 0.09 0.1
Total Current Liabilities 28.96 32.125 22.6 4.468
Accounts Payable 1.662 8.964 1.717 0.886
Accrued Expenses 4.899 4.69 1.899 1.568
Notes Payable/Short Term Debt 0 0 12.045 0
Other Current Liabilities, Total 22.38 6.631 6.939 2.014
Total Liabilities 56.37 79.904 76.213 53.125
Total Long Term Debt 9.993 15.926 23.812 23.099
Long Term Debt 9.993 15.926 23.812 23.099
Other Liabilities, Total 17.417 31.853 29.801 25.558
Total Equity 19.727 41.166 -34.58 -14.068
Redeemable Preferred Stock 0 0 193.959 183.962
Common Stock 0.031 0.027 0.001 0.001
Additional Paid-In Capital 321.669 299.953 2.324 2.107
Retained Earnings (Accumulated Deficit) -301.973 -258.814 -230.864 -200.138
Total Liabilities & Shareholders’ Equity 76.097 121.07 41.633 39.057
Total Common Shares Outstanding 30.7896 26.5615 26.2541 26.2541
Current Port. of LT Debt/Capital Leases 0.019 11.84 0
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Total Current Assets 27.233 43.613 56.445 68.45 81.244
Cash and Short Term Investments 16.427 32.712 47.913 56.349 55.329
Cash & Equivalents 16.427 32.712 47.913 56.349 55.329
Total Receivables, Net 3.774 3.656 2.784 5.281 18.367
Accounts Receivable - Trade, Net 3.774 3.656 2.784 5.281 18.367
Other Current Assets, Total 7.032 7.245 5.748 6.82 7.548
Total Assets 61.651 76.097 89.997 101.804 115.486
Property/Plant/Equipment, Total - Net 6.247 4.179 4.432 3.378 3.387
Property/Plant/Equipment, Total - Gross 13.409 10.928 11.827 10.471 10.369
Accumulated Depreciation, Total -7.162 -6.749 -7.395 -7.093 -6.982
Goodwill, Net 15.031 15.031 15.031 15.031 15.031
Intangibles, Net 11.131 11.617 11.992 12.4 12.821
Other Long Term Assets, Total 2.009 1.657 2.097 2.545 3.003
Total Current Liabilities 29.811 28.96 22.787 21.272 16.124
Accounts Payable 2.12 1.662 1.6 1.16 3.747
Accrued Expenses 4.597 4.899 3.533 2.959 2.622
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 0.051 0.019 0.02 3.106 2.707
Other Current Liabilities, Total 23.043 22.38 17.634 14.047 7.048
Total Liabilities 53.87 56.37 73.964 76.031 79.054
Total Long Term Debt 10.055 9.993 29.975 29.955 30.328
Long Term Debt 10.055 9.993 29.975 29.955 30.328
Other Liabilities, Total 14.004 17.417 21.202 24.804 32.602
Total Equity 7.781 19.727 16.033 25.773 36.432
Redeemable Preferred Stock 0 0 0 0
Common Stock 0.032 0.031 0.027 0.027 0.027
Additional Paid-In Capital 325.308 321.669 304.697 302.923 302.18
Retained Earnings (Accumulated Deficit) -317.559 -301.973 -288.691 -277.177 -265.775
Total Liabilities & Shareholders’ Equity 61.651 76.097 89.997 101.804 115.486
Total Common Shares Outstanding 31.8893 30.7896 27.0201 26.9489 26.7854
  • Annual
  • Quarterly
2021 2020 2019 2018
Net income/Starting Line -43.159 -31.35 -30.726 -26.166
Cash From Operating Activities -28.223 -21.366 -21.726 -17.677
Cash From Operating Activities 3.178 2.903 2.793 1.74
Non-Cash Items 7.167 11.882 7.852 6.496
Changes in Working Capital 4.591 -4.801 -1.645 0.253
Cash From Investing Activities -2.547 -2.927 -1.872 -0.617
Capital Expenditures -2.547 -2.177 -1.416 -0.617
Other Investing Cash Flow Items, Total 0 -0.75 -0.456 0
Cash From Financing Activities 1.262 81.131 22.972 19.032
Financing Cash Flow Items -0.5 -8.249 -0.119 -0.283
Issuance (Retirement) of Stock, Net 17.112 73.34 10.047 8.55
Issuance (Retirement) of Debt, Net -15.35 16.04 13.044 10.765
Net Change in Cash -29.508 56.838 -0.626 0.738
Cash Interest Paid 1.676 1.844
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Net income/Starting Line -15.586 -43.159 -29.877 -18.363 -6.961
Cash From Operating Activities -13.099 -28.223 -18.026 -10.236 -11.326
Cash From Operating Activities 0.908 3.178 2.323 1.523 0.746
Non-Cash Items 2.674 7.167 4.704 5.336 3.721
Changes in Working Capital -1.095 4.591 4.824 1.268 -8.832
Cash From Investing Activities -0.352 -2.547 -1.906 -0.864 -0.516
Capital Expenditures -0.352 -2.547 -1.906 -0.864 -0.516
Other Investing Cash Flow Items, Total 0 0 0 0
Cash From Financing Activities -2.834 1.262 5.625 5.229 4.951
Financing Cash Flow Items -4.6 -0.5 0.232 -0.109 -0.108
Issuance (Retirement) of Stock, Net 1.674 17.112 0.739 0.679 0.475
Issuance (Retirement) of Debt, Net 0.092 -15.35 4.654 4.659 4.584
Net Change in Cash -16.285 -29.508 -14.307 -5.871 -6.891
Cash Interest Paid 0.223
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
Schuler (Jack W) Individual Investor 25.5879 19952112 8695652 2022-11-21
Kennedy (Lawrence T Jr.) Individual Investor 19.0156 14827404 0 2023-01-03 MED
Patience (John) Individual Investor 9.0025 7019695 1739130 2022-11-21 LOW
Birchview Capital, LP Investment Advisor 6.4632 5039633 2884624 2022-12-31 LOW
AIGH Capital Management, LLC. Private Equity 5.8936 4595512 -973389 2022-12-31 MED
Cawthorn (Robert E) Individual Investor 4.6838 3652220 1723341 2022-11-21 LOW
Strobeck (Matthew W) Individual Investor 3.7251 2904668 1304345 2022-11-21 LOW
Industrial Development Funding LLC Corporation 2.432 1896374 0 2022-03-01 LOW
Worth Venture Partners, LLC Investment Advisor/Hedge Fund 1.9211 1497963 1497963 2022-12-31 HIGH
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 1.4189 1106403 866747 2022-12-31 LOW
Wells Fargo Advisors Research Firm 0.9923 773725 5000 2022-12-31 LOW
Essex Investment Management Company, LLC Investment Advisor/Hedge Fund 0.4848 377994 -29 2022-12-31 LOW
Life Sciences Alternative Financing, L.L.C. Corporation 0.3771 294053 0 2022-03-01 LOW
Cannell & Co. Investment Advisor 0.2637 205605 0 2022-12-31 LOW
Hutton Scott Individual Investor 0.2561 199726 28499 2023-02-09 HIGH
Massarany (Hany) Individual Investor 0.1769 137934 130434 2022-11-21 HIGH
Hightower Advisors, LLC Investment Advisor 0.175 136434 136434 2022-12-31 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.1617 126122 2052 2022-12-31 LOW
Endurant Capital Management LP Hedge Fund 0.1596 124430 -5706 2022-12-31 HIGH
Millennium Management LLC Hedge Fund 0.1382 107788 -10260 2022-12-31 HIGH

Mengapa memilih Capital.com? Biarlah angka kami yang berbicara.

Capital.com Group

500K+

Trader

92K+

Klien aktif per bulan

$53M+

Volume investasi per bulan

$30M+

Penarikan tiap bulan

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long
Industry: Medical & Diagnostic Laboratories

Suite 100
2970 Wilderness Place
BOULDER
COLORADO 80301
US

Income Statement

  • Annual
  • Quarterly

People also watch

US100

12,791.00 Price
+1.240% 1D Chg, %
Biaya inap posisi Long -0.0241%
Biaya inap posisi short 0.0018%
Waktu biaya inap 21:00 (UTC)
Spread 1.8

Oil - Crude

73.62 Price
-0.080% 1D Chg, %
Biaya inap posisi Long -0.0153%
Biaya inap posisi short -0.0066%
Waktu biaya inap 21:00 (UTC)
Spread 0.03

Gold

1,967.27 Price
-0.360% 1D Chg, %
Biaya inap posisi Long -0.0180%
Biaya inap posisi short 0.0097%
Waktu biaya inap 21:00 (UTC)
Spread 0.30

BTC/USD

28,488.65 Price
+4.090% 1D Chg, %
Biaya inap posisi Long -0.0616%
Biaya inap posisi short 0.0137%
Waktu biaya inap 21:00 (UTC)
Spread 66.00

Masih mencari broker yang bisa Anda percayai?

Bergabung dengan 500.000+ trader di seluruh dunia yang telah memilih trading bersama Capital.com

1. Buat & verifikasi akun Anda 2. Lakukan deposit 3. Temukan trading Anda